Free delivery nationwide for orders above ₱800

 
RXDRUG-BR-1333

HEMLIBRA Emicizumab 105mg / 0.7mL Solution for Injection (SC) 3mL 1's

Contact us for a price
Out of stock
Discreet Packaging
FDA-registered Products
FDA-licensed Pharmacies
Description

Indications/Uses

Prophylaxis to prevent bleeding or reduce frequency of bleeding episodes in adults & childn w/ hemophilia A (congenital factor VIII deficiency) w/ or w/o factor VIII inhibitors.
 

Dosage/Direction for Use

SC Loading dose: 3 mg/kg once wkly for the 1st 4 wk followed by maintenance dose from wk 5 of either 1.5 mg/kg once wkly or 3 mg/kg every 2 wk or 6 mg/kg every 4 wk.
 

Contraindications

Hypersensitivity.
 

Special Precautions

Monitor for the development of TMA &/or thromboembolism when administering aPCC. Discontinue bypassing agents the day before starting therapy. Hepatic & renal impairment. Pregnancy & lactation. Childn. Elderly.
 

Adverse Reactions

Inj site reactions; headache; arthralgia. Pyrexia; diarrhea; myalgia.
 

MedsGo Class

Haemostatics

Features

Brand
Hemlibra
Full Details
Dosage Strength
105 mg / 0.7 ml
Drug Ingredients
  • Emicizumab
Drug Packaging
Solution for Injection (S.C.) 3ml x 1's
Generic Name
Emicizumab
Dosage Form
Solution For Injection (S.C.)
Registration Number
BR-1333
Drug Classification
Prescription Drug (RX)
Find similar